ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

Adjuvant Nutrition Breast Cancer Study Offered To Groups

March 19, 1982

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

First analysis From Profiles Reveal New Data On Centers

November 18, 1977

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994